Work

A phase II trial evaluating combination pemetrexed and avelumab in patients with MTAP-deficient advanced urothelial cancer.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.16_suppl.tps4612

Authors: Amishi Yogesh Shah, Matthew T Campbell, Rebecca Tidwell, Arlene O. Siefker-Radtke, Sangeeta Goswami, Omar Alhalabi, Ana Cecilia Adriazola, Leah Shaw, Yin Ye, Jianfeng Chen, Xinmiao Yan, Linghua Wang, Jianjun Gao

Institutions: The University of Texas MD Anderson Cancer Center, Beaumont Health, Baylor College of Medicine

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: EMD Serono

OpenAlex ID: W4286295713

Cites:

Cited by: 3

Related to: 10